UK news
fromwww.theguardian.com
1 month agoChildren with cancer cannot wait': the human cost of clinical trial delays after Brexit
Brexit is complicating cancer trials in the UK, raising costs and causing delays, preventing patients from accessing new treatments.
The eSMART trial faces significant logistical challenges post-Brexit.